Lynette Sholl
Overview
Explore the profile of Lynette Sholl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chou T, Dacic S, Wistuba I, Beasley M, Berezowska S, Chang Y, et al.
J Thorac Oncol
. 2024 Nov;
20(3):311-330.
PMID: 39579981
Introduction: With the implementation of low-dose computed tomography screening, multiple pulmonary tumor nodules are diagnosed with increasing frequency and the selection of surgical treatments versus systemic therapies has become challenging...
2.
Cooper W, Webster F, Butnor K, Calabrese F, Chou T, Hwang D, et al.
Histopathology
. 2024 Oct;
86(5):665-680.
PMID: 39438780
Lung cancer is the leading cause of cancer related deaths worldwide, although some patients with early-stage disease can be cured with surgical resection. Standardised reporting of all clinically relevant pathological...
3.
Vaz V, Gandhi M, Ricciuti B, Alessi J, Elkrief A, Ladanyi M, et al.
JCO Precis Oncol
. 2024 Oct;
8:e2400394.
PMID: 39374479
Crizotinib successfully overcomes MET amplification in ROS1-rearranged NSCLC after entrectinib failure.
4.
Gilbert C, Dust C, Argento A, Feller-Kopman D, Gonzalez A, Herth F, et al.
Chest
. 2024 Sep;
167(3):899-909.
PMID: 39343294
Background: Endobronchial ultrasound-guided transbronchial aspiration (EBUS-TBNA) has become the standard for initial lung cancer diagnosis and staging. Previous guidelines have generally focused on the "when" and "how" of EBUS-TBNA; however,...
5.
Wang X, Zhao J, Marostica E, Yuan W, Jin J, Zhang J, et al.
Nature
. 2024 Sep;
634(8035):970-978.
PMID: 39232164
Histopathology image evaluation is indispensable for cancer diagnoses and subtype classification. Standard artificial intelligence methods for histopathology image analyses have focused on optimizing specialized models for each diagnostic task. Although...
6.
Priedigkeit N, Harrison B, Shue R, Hughes M, Li Y, Kirkner G, et al.
bioRxiv
. 2024 May;
PMID: 38766070
Background: Inflammatory breast cancer (IBC) is a rare and poorly characterized type of breast cancer with an aggressive clinical presentation. The biological mechanisms driving the IBC phenotype are relatively undefined-partially...
7.
Tarantino P, Gupta H, Hughes M, Files J, Strauss S, Kirkner G, et al.
Nat Commun
. 2023 Dec;
14(1):8321.
PMID: 38097580
No abstract available.
8.
Dacic S, Travis W, Giltnane J, Kos F, Abel J, Hilz S, et al.
J Thorac Oncol
. 2023 Dec;
19(5):719-731.
PMID: 38070597
Introduction: Pathologic response (PathR) by histopathologic assessment of resected specimens may be an early clinical end point associated with long-term outcomes with neoadjuvant therapy. Digital pathology may improve the efficiency...
9.
Tarantino P, Gupta H, Hughes M, Files J, Strauss S, Kirkner G, et al.
Nat Commun
. 2023 Nov;
14(1):7496.
PMID: 37980405
The molecular underpinnings of HER2-low and HER2-0 (IHC 0) breast tumors remain poorly defined. Using genomic findings from 1039 patients with HER2-negative metastatic breast cancer undergoing next-generation sequencing from 7/2013-12/2020,...
10.
Gandhi M, Ricciuti B, Harada G, Repetto M, Gildenberg M, Singh A, et al.
JCO Precis Oncol
. 2023 Nov;
7:e2300295.
PMID: 37972337
Purpose: rearrangements and activating point mutations represent targetable genomic alterations in advanced solid tumors. However, the frequency and clinicopathologic characteristics of wild-type amplification in cancer and its potential role as...